Canada Pension Plan Investment Board’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.8M Buy
85,478
+54,815
+179% +$12.8M 0.01% 527
2026
Q1
$7.01M Sell
30,663
-40,853
-57% -$9.16M ﹤0.01% 720
2025
Q4
$15.3M Buy
71,516
+44,985
+170% +$9.29M 0.01% 558
2025
Q3
$5.27M Buy
+26,531
New +$4.95M ﹤0.01% 752
2019
Q3
– Sell
-11,100
Closed -$1.28M – 1189
2019
Q2
$1.28M Buy
+11,100
New +$1.33M ﹤0.01% 1011

Other funds holding ASND

Canada Pension Plan Investment Board's ASND Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Ascendis Pharma A/S (ASND) stake by 179% in Q2 2026, buying an estimated $12.8M and bringing the position to 85,478 shares worth $22.8M. The position accounts for 0.01% of the portfolio, ranked #527.

Canada Pension Plan Investment Board first reported a position in ASND in Q2 2019 and has held it in 5 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Canada Pension Plan Investment Board held 85,478 shares of Ascendis Pharma A/S worth $22.8M as of Q2 2026.
  • Canada Pension Plan Investment Board bought 54,815 Ascendis Pharma A/S shares in Q2 2026, an estimated $12.8M.
  • Ascendis Pharma A/S made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #527 holding.
  • Canada Pension Plan Investment Board first reported a position in Ascendis Pharma A/S in Q2 2019 and has held it in 5 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.